Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone

Leukemia Research

Volumn 31, Issue 2, 2007, Pages 261-265

  Pullarkat, Vinod ^a   Bedell, Victoria ^a   Kim, Young ^a   Bhatia, Ravi ^a   Nakamura, Ryotaro ^a   Forman, Stephen ^a   Sun, Jiyao ^a   Senitzer, David ^a   Slovak, Marilyn L ^a  

^a Division of Biology   (United States)

Author keywords

Acute myeloid leukemia; Cytogenetics; KIT mutations; Pathogenesis; Systemic mastocytosis; Translocation(8 ; 21)

Indexed keywords

CYCLOSPORIN; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; METHOTREXATE; STEM CELL FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW BIOPSY; BONE MARROW CELL; CASE REPORT; CELL INFILTRATION; CELL LINEAGE; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 8; DISEASE ASSOCIATION; DRUG MEGADOSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE ACTIVATION; GENE MUTATION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA CELL; MAST CELL; PRIORITY JOURNAL; SYSTEMIC MASTOCYTOSIS; TUMOR CELL;

ACUTE DISEASE; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 8; CYTOGENETIC ANALYSIS; EXONS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID; MAST CELLS; MASTOCYTOSIS, SYSTEMIC; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 33845193026     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.03.006     Document Type: Article

References (14)

1. Valent P., Horny H.-P., Li C.Y., et al. Mastocytosis. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). In Tumors of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon, France 104-105
2. Pullarkat V.A., Bueso-Ramos C., Lai R., et al. Systemic mastocytosis with associated clonal hemayological non-mast cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations. Am J Hematol 73 (2003) 12-17
3. Nagata H., Worobec A.S., Oh C.K., et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 92 (1995) 10560-10564
4. Zhang D.-E., and Peterson L.F. The 8;21 translocation in leukemogenesis. Oncogene 23 (2004) 4255-4262
5. Beghini A., Peterlongo P., Ripamonti C.B., et al. C-kit mutations in core binding factor leukemia. Blood 95 (2000) 726-727
6. Cairolo R., Grillo G., Beghini A., et al. C-kit point mutations in core binding factor leukemias: correlation with white blood cell count and white blood cell index. Leukemia 17 (2003) 471-472
7. Pardanani A., Kimlinger T., Reeder T., Li C.-Y., and Tefferi A. Bone marrow mast cell immunophenotyping in adults with mast cell disease: a prospective study of 33 patients. Leuk Res 28 (2004) 777-783
8. Yuan Y., Zhou L., Miyamoto T., et al. AML-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations. Proc Natl Acad Sci USA 98 (2001) 10398-10403
9. Grisolano J.L., O'Neal J., Cain J., and Tomasson M.H. An activated receptor tyrosine kinase, TEL/PDGF, cooperates with AML1/ETO to induce acute myeloid leukemia in mice. Proc Natl Acad Sci USA 100 (2003) 9506-9511
10. Rhoades K.L., Hetherington C.J., Harakawa N., et al. Analysis of the role of AML-ETO in leukemogenesis using an inducible transgenic mouse model. Blood 96 (2000) 2108-2115
11. Mulloy J.C., Cammenga J., Berguido F.J., et al. Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element. Blood 102 (2003) 4369-4376
12. Wang Y.-Y., Zhou G.-B., Yin T., et al. AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec. Proc Natl Acad Sci USA 102 (2005) 1104-1109
13. Sperr W.R., Drach J., Hauswirth A.W., et al. Myelomastocytic leukemia: evidence for the origin of mast cells from the leukemic clone and eradication by allogeneic stem cell transplantation. Clin Cancer Res 11 (2005) 6787-6792
14. Spyridonidia A., Thomas A.K., Bertz H., et al. Evidence for a graft-versus-mast-cell effect after allogeneic bone marrow transplantation. Bone Marrow Transplant 34 (2004) 515-519